Written Question·Department of Health and Social Care·UIN 16569

Menopause: Drugs

Tabled: 7 July 2026

Answered: 15 July 2026

Question

Dr Luke Evans

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure consistent access across Integrated Care Boards to non-hormonal menopause treatments, including fezolinetant.

Answer

Preet Kaur Gill

The National Institute for Health and Care Excellence (NICE) published guidance on 31 March 2026 recommending fezolinetant as an option for treating moderate to severe menopause-related hot flushes and night sweats when hormone replacement therapy is unsu...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 16569) →